ArticleBMC public health2025
Hepatitis B vaccination coverage and associated factors among adults in Somalia: a cross-sectional study.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Global spatiotemporal analysis in hepatitis B third dose vaccine coverage from 1980-2023 across 204 countries and territories.Human vaccines & immunotherapeutics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatitis B virus (HBV) remains a significant global health concern with substantial morbidity and mortality. Although effective vaccines exist, vaccination coverage remains suboptimal in many low- and middle-income countries, including Somalia. This descriptive cross-sectional study aimed to assess Coverage of the complete hepatitis B vaccination series and identify associated demographic, occupational, and health-related factors among Somali adults.
methodsThis cross-sectional study was conducted in Somalia from April 2024 to November 2024. Data were collected through structured face-to-face interviews and validated with hospital records at multiple healthcare institutions, universities, and community settings. Hepatitis B coverage was defined as completion of the full three-dose series. Binary logistic regression was used to identify factors associated with adherence.
resultsAmong 10,300 recruited participants, 9,975 had complete data for analysis. Hepatitis B vaccination adherence was high (81.91%). Females constituted the majority (55.05%), with most being single (56.65%), students (62.50%), and urban residents (89.37%). Significant factors associated with adherence included gender, education level, occupation, residence, and prior health conditions. Females, university graduates, healthcare workers, and hospital staff had notably lower adherence rates. Logistic regression identified male gender (OR = 4.91), student status (OR = 3.64), and urban residence (OR = 3.27) as strong positive predictors of vaccine completion. In contrast, hospital staff (OR = 0.37) and university students (OR = 0.17) had significantly lower odds of adherence. These results highlight the need for targeted interventions among specific subgroups to improve vaccination uptake.
conclusionThis study reveals a promising hepatitis B coverage rate in Somalia, with key disparities linked to gender, occupation, education, and residence. Addressing these disparities will require context-specific, multi-pronged strategies that combine expanded access, targeted communication, and flexible delivery methods to reach underserved and high-risk populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.